Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

Caroline Benedicte Kjærulff Mathiesen

Publikation: Konferencebidrag uden forlag/tidsskriftPosterFormidling

OriginalsprogDansk
Publikationsdato29 aug. 2018
StatusUdgivet - 29 aug. 2018
BegivenhedBenzon Symposia - 2018 - Hotel skt. Petri
Varighed: 27 aug. 201830 aug. 2018

Konference

KonferenceBenzon Symposia - 2018
LokationHotel skt. Petri
Periode27/08/1830/08/18

Citationsformater